Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
321.4 USD | -0.77% |
|
+2.17% | +46.15% |
Jul. 11 | TD Cowen Adjusts Price Target on United Therapeutics to $350 From $270, Maintains Buy Rating | MT |
Jul. 11 | Everything's going according to plan | ![]() |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.15% | 14.26B | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+44.52% | 13.69B | |
+0.19% | 12.18B | |
-8.55% | 11.14B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- Transcript : United Therapeutics Corporation Presents at 36th Annual J.P. Morgan Healthcare Conference, Jan-08-2018 01